Literature DB >> 17945361

Requirement for the POZ/BTB protein NAC1 in acute but not chronic psychomotor stimulant response.

Scott Mackler1, Alejandra Pacchioni, Ryan Degnan, Ying Homan, Alana C Conti, Peter Kalivas, Julie A Blendy.   

Abstract

NAC1 is a novel member of the POZ/BTB (Pox virus and Zinc finger/Bric-a-bracTramtrack Broad complex) but varies from other proteins of this class in that it lacks the characteristic DNA-binding motif, suggesting a novel role. We have employed constitutive gene deletion to elucidate the role of NAC1 in vivo. Nac1 mutant mice are viable with no obvious developmental or physiological impairments. Previous studies suggest a role for NAC1 in cocaine-mediated behaviors. Therefore, we evaluated a variety of behaviors associated with psychomotor stimulant effects in Nac1 mutant mice. Acute locomotor activating effects of cocaine or amphetamine are absent in Nac1 mutant mice, however longer exposure to these psychomotor stimulants result in the development of behavioral sensitization. Acute rewarding properties of cocaine and amphetamine are also blunted in mutant mice, yet repeated exposure resulted in conditioned place preference similar to that observed in wild-type mice. Lastly, increases in extracellular dopamine in the nucleus accumbens, which accompany acute cocaine administration, are blunted in mutant mice, but following chronic cocaine extracellular dopamine levels are increased to the same extent as in wild-type mice. Together these data indicate involvement of NAC1 in the acute behavioral and neurochemical responses to psychomotor stimulants.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17945361      PMCID: PMC2248375          DOI: 10.1016/j.bbr.2007.08.036

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  22 in total

1.  Differences in expression, actions and cocaine regulation of two isoforms for the brain transcriptional regulator NAC1.

Authors:  L Korutla; P J Wang; D M Lewis; J H Neustadter; M F Stromberg; S A Mackler
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

Review 2.  Molecular neurobiology of addiction.

Authors:  E J Nestler
Journal:  Am J Addict       Date:  2001

Review 3.  Cellular and molecular mechanisms of drug dependence.

Authors:  G F Koob; F E Bloom
Journal:  Science       Date:  1988-11-04       Impact factor: 47.728

4.  The BTB/POZ domain: a new protein-protein interaction motif common to DNA- and actin-binding proteins.

Authors:  O Albagli; P Dhordain; C Deweindt; G Lecocq; D Leprince
Journal:  Cell Growth Differ       Date:  1995-09

5.  Universal beta-galactosidase cloning vectors for promoter analysis and gene targeting.

Authors:  K H Kaestner; L Montoliu; H Kern; M Thulke; G Schütz
Journal:  Gene       Date:  1994-10-11       Impact factor: 3.688

6.  Lack of reward and locomotor stimulation induced by heroin in mu-opioid receptor-deficient mice.

Authors:  Angelo Contarino; Roberto Picetti; Hans W Matthes; George F Koob; Brigitte L Kieffer; Lisa H Gold
Journal:  Eur J Pharmacol       Date:  2002-06-20       Impact factor: 4.432

7.  The relationship between cocaine-induced increases in NAC1 and behavioral sensitization.

Authors:  P J Wang; Michael Stromberg; Stephen Replenski; Alexander Snyder-Mackler; Scott A Mackler
Journal:  Pharmacol Biochem Behav       Date:  2003-04       Impact factor: 3.533

8.  Activator of G protein signaling 3: a gatekeeper of cocaine sensitization and drug seeking.

Authors:  M Scott Bowers; Krista McFarland; Russell W Lake; Yuri K Peterson; Christopher C Lapish; Mary Lee Gregory; Stephen M Lanier; Peter W Kalivas
Journal:  Neuron       Date:  2004-04-22       Impact factor: 17.173

9.  Repeated cocaine administration changes the function and subcellular distribution of adenosine A1 receptor in the rat nucleus accumbens.

Authors:  Shigenobu Toda; Luis F Alguacil; Peter W Kalivas
Journal:  J Neurochem       Date:  2003-12       Impact factor: 5.372

10.  The mouse nac1 gene, encoding a cocaine-regulated Bric-a-brac Tramtrac Broad complex/Pox virus and Zinc finger protein, is regulated by AP1.

Authors:  S A Mackler; Y X Homan; L Korutla; A C Conti; J A Blendy
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

View more
  6 in total

1.  Identification of the NAC1-regulated genes in ovarian cancer.

Authors:  Min Gao; Ren-Chin Wu; Alice L Herlinger; Kailee Yap; Jung-Won Kim; Tian-Li Wang; Ie-Ming Shih
Journal:  Am J Pathol       Date:  2013-11-06       Impact factor: 4.307

2.  Targeted gene mutation of E2F1 evokes age-dependent synaptic disruption and behavioral deficits.

Authors:  Jenhao H Ting; David R Marks; Stephanie S Schleidt; Joanna N Wu; Jacob W Zyskind; Kathryn A Lindl; Julie A Blendy; R Christopher Pierce; Kelly L Jordan-Sciutto
Journal:  J Neurochem       Date:  2014-02-12       Impact factor: 5.372

3.  Anxiolytic- and antidepressant-like effects of the methadone metabolite 2-ethyl-5-methyl-3,3-diphenyl-1-pyrroline (EMDP).

Authors:  Patrick A Forcelli; Jill R Turner; Bridgin G Lee; Thao T Olson; Teresa Xie; Yingxian Xiao; Julie A Blendy; Kenneth J Kellar
Journal:  Neuropharmacology       Date:  2015-09-11       Impact factor: 5.250

4.  Cocaine-related behaviors in mice with deficient gliotransmission.

Authors:  Jill R Turner; Laurel E Ecke; Lisa A Briand; Philip G Haydon; Julie A Blendy
Journal:  Psychopharmacology (Berl)       Date:  2012-10-27       Impact factor: 4.530

5.  NAC-1, a potential stem cell pluripotency factor, contributes to paclitaxel resistance in ovarian cancer through inactivating Gadd45 pathway.

Authors:  N Jinawath; C Vasoontara; K-L Yap; M M Thiaville; K Nakayama; T-L Wang; I-M Shih
Journal:  Oncogene       Date:  2009-03-23       Impact factor: 9.867

6.  Loss of NAC1 expression is associated with defective bony patterning in the murine vertebral axis.

Authors:  Kai Lee Yap; Polina Sysa-Shah; Brad Bolon; Ren-Chin Wu; Min Gao; Alice L Herlinger; Fengying Wang; Francesco Faiola; David Huso; Kathleen Gabrielson; Tian-Li Wang; Jianlong Wang; Ie-Ming Shih
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.